Remove 2014 Remove Bioethics Remove Fraud Remove Licensing
article thumbnail

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Health Populi

When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 Shkreli was ultimately convicted on securities fraud (not related to the Draprim pricing strategy). a pill to $750 a pill.